Could Cholesterol-Lowering Drugs Improve Cancer Immunotherapy?

SEMrush
Cholesterol-lowering drugs known as PCSK9 inhibitors may improve the effectiveness of cancer immune checkpoint inhibitors, according to studies in mice. The drugs appear to improve the immunotherapy drugs’ ability to find tumors and slow their growth.
[automaticbacklinks]